News blog

Texas cancer agency reveals another grant misstep

The embattled agency charged with doling out $3 billion in Texas taxpayer money for cancer research and prevention has discovered during an audit another unreviewed commercialization grant. The Cancer Prevention and Research Institute of Texas (CPRIT) announced yesterday that it has put a hold on the $11 million award and that the company that received it, Dallas-based Peloton Therapeutics, has resubmitted the proposal for commercial and scientific review. 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE